TBPH vs AMGN: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Amgen Inc in 2026
TBPH
Theravance Biopharma Inc
—
AMGN
Amgen Inc
$360.55
Key Metrics Comparison
| Metric | TBPH | AMGN | Winner |
|---|---|---|---|
| Market Cap | $861.45M | $188.67B | AMGN |
| P/E Ratio | 7.49 | 24.33 | TBPH |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TBPH
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or AMGN a better investment?
Comparing TBPH and AMGN: Theravance Biopharma Inc has a market cap of $861.45M while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and AMGN?
TBPH (Theravance Biopharma Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or AMGN?
Based on P/E ratios, TBPH trades at a lower multiple (7.5x vs 24.3x).
Which is growing faster: TBPH or AMGN?
Both TBPH and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TBPH or AMGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TBPH or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $861.45M for TBPH.
Should I buy TBPH or AMGN in 2026?
Both TBPH and AMGN have investment merit. TBPH trades at $N/A while AMGN trades at $360.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and AMGN stock?
Key differences: Market Cap ($861.45M vs $188.67B), P/E Ratio (7.5x vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TBPH or AMGN in 2026?
The choice between TBPH and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TBPH and AMGN?
TBPH (Theravance Biopharma Inc) has a market cap of $861.45M, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.